Furthermore, tumor analysis in four VHL patients bearing ccRCC who received propranolol as an off-label treatment for retinal HBs showed a stabilization in tumor growth after three years (on average) of systemic treatment [2]. Here, VHL is linked to nonpapillary renal cell carcinoma.